Request Demo

Last update 08 May 2025

Biotechnology Research & Development Corp.

Private Company|Illinois, United States

Last update 08 May 2025

Overview

Pipeline

Deal

Translational Medicine

Overview

100 Clinical Results associated with Biotechnology Research & Development Corp.

0 Patents (Medical) associated with Biotechnology Research & Development Corp.

Literatures (Medical) associated with Biotechnology Research & Development Corp.

01 Jan 2022·Journal of Food Science and TechnologyQ3 · AGRICULTURAL & FORESTRY SCIENCE

Microbiological quality of tempeh with different wraps: banana leaf versus plastic

Q3 · AGRICULTURAL & FORESTRY SCIENCE

Article

Author: Meryandini, Anja ; Wijaya, Michael ; Erdiansyah, Muhammad ; Suwanto, Antonius

Tempeh is a traditional Indonesian fermented food widely consumed and became staple food in some Indonesian diet. Commercially, tempeh is available in banana leaf or plastic wraps. The wraps are not only important for fermentation and giving final form of tempeh, but also potential source of food microbiome. This study aimed to investigate the effect of different packaging materials on the lactic acid bacteria (LAB) quantity and community composition of tempeh from three manufacturers with different production environments. Each tempeh wrapped with banana leaf or plastic during the fermentation process and then LAB from every tempeh sample were quantified using qPCR and plate count method. Terminal Restriction Fragment Length Polymorphism analysis was carried out to assign bacterial community composition from these samples. The LAB population quantity of fresh tempeh from three manufacturers were essentially similar around 10 log CFU/g. However, there is a difference in the proportion of cultured and uncultured bacteria. Principal Coordinate Analyses based on Bray-Curtis similarity matrices showed an apparent clustering pattern for tempeh samples according to tempeh manufacturers. Meanwhile, packaging materials did not significantly influence changes in bacterial community composition. The result of this work could be used for determination, authentication, and improvement of tempeh quality.

01 Sep 2020·Agriculture and Human ValuesQ2 · LAW

Keeping up with the fast-moving world of crisis management

Q2 · LAW

Article

Author: Kebreab, Ermias ; Jones, James W ; Hamer, John ; Czarnecki-Maulden, Gail ; Kelley, Stephen S ; Lougee, Robin ; Salvador, Ricardo J ; Rice, Charles W ; Burgess, Shane C ; Sample, V Alaric ; McCluskey, Jill J ; Gould, Fred ; Aristidou, Aristos ; Famigilietti, Jay S ; Jackson-Smith, Douglas B ; Dunham, Bernadette ; Leach, Jan E ; Schoen, Robin ; Capalbo, Susan ; Ejeta, Gibesa ; Plaut, Karen I

Author(s): Rice, Charles W; Schoen, Robin; Aristidou, Aristos; Burgess, Shane C; Capalbo, Susan; Czarnecki-Maulden, Gail; Dunham, Bernadette; Ejeta, Gibesa; Famigilietti, Jay S; Gould, Fred; Hamer, John; Jackson-Smith, Douglas B; Jones, James W; Kebreab, Ermias; Kelley, Stephen S; Leach, Jan E; Lougee, Robin; McCluskey, Jill J; Plaut, Karen I; Salvador, Ricardo J; Sample, V Alaric

01 Jan 2020·mAbsQ2 · MEDICINE

Anti-ErbB2 immunotherapeutics: struggling to make better antibodies for cancer therapy

Q2 · MEDICINE

Review

Author: De Santis, Rita

Over the past 3 decades, monoclonal antibodies and their related derivatives, including recently approved antibody-drug conjugates, conquered a central role in cancer therapy because of their contribution to improve survival, time to progression and quality of life of patients compared to chemotherapy protocols. This review summarizes information on approved original and biosimilar products, as well as investigational antibody-based therapeutics, targeting ErbB2. This target has been selected as a paradigmatic example because of its relevant role in sustaining the malignancy of major cancer diseases including, breast, gastric and other chemotherapy-resistant solid tumors. This work analyzes the drivers affecting research and development of next-generation anti-ErbB2 immunotherapeutics, taking into account unmet medical needs and pharmacoeconomic issues related to sustainability. The analysis may help with the design of future research and development strategies.

100 Deals associated with Biotechnology Research & Development Corp.

100 Translational Medicine associated with Biotechnology Research & Development Corp.

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 17 May 2025

No data posted

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis

Biotechnology Research & Development Corp.

Overview

Related

Corporation Tree

Pipeline

Pipeline Snapshot as of 17 May 2025

Deal

Translational Medicine

Profit

Grant & Funding(NIH)

Investment

Financing